Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Vaxcel acquires rights to cancer antigen

April 6, 1998

Preclinical data indicates efficacy of AltaRex's approach to cancer immunotherapy

April 2, 1998

Merck KGaA initiates worldwide cancer study with BEC2

April 2, 1998

Genentech receives fast track product designation for Herceptin

April 2, 1998

Dendreon's dendritic cell-based immunotherapy reported at AACR

March 30, 1998

Novel fusion protein with potent activity in colon cancer models reported at AACR

March 30, 1998

U.S. patent issues for Immunex's soluble CD40 ligand

March 30, 1998

Canadian notice of patent allowance for Imutec's Virulizin

March 30, 1998

Promising preliminary results obtained with Melacine/Intron A combination in stage IV melanoma

March 27, 1998

Cytogen halts autologous lymphocyte therapy program

March 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...